Selvita (WSE:SLV) - Aandelenkoers, Nieuws & Analyse

SLV Overzicht aandelen

Selvita S.A. is wereldwijd actief als organisatie voor contractonderzoek.

SLV fundamentele analyse
Sneeuwvlok Score
Waardering	6/6
Toekomstige groei	4/6
Prestaties in het verleden	5/6
Financiële gezondheid	4/6
Dividenden	0/6

Beloningen

Trading at 43.3% below our estimate of its fair value

Earnings are forecast to grow 20.13% per year

Earnings grew by 54.1% over the past year

Trading at good value compared to peers and industry

Analysts in good agreement that stock price will rise by 29.7%

Risicoanalyse

Geen risico's gedetecteerd voor SLV uit onze risicocontroles.

Selvita S.A. Concurrenten

Synthaverse

WSE:SVE

zł304.3m

Fine Foods & Pharmaceuticals N.T.M

BIT:FF

€204.2m

Frontage Holdings

SEHK:1521

HK$1.8b

Tarsons Products

NSEI:TARSONS

₹21.7b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Selvita
Historische aandelenkoersen
Huidige aandelenkoers	zł53.70
52 Week Hoogtepunt	zł73.00
52 Week Laag	zł50.40
Bèta	-0.0028
11 maand verandering	-5.29%
3 maanden verandering	-17.38%
1 Jaar Verandering	-9.75%
33 jaar verandering	-34.11%
5 jaar verandering	114.80%
Verandering sinds IPO	155.71%

Recent nieuws en updates

Is Selvita (WSE:SLV) Using Too Much Debt?

Sep 26

It's Unlikely That The CEO Of Selvita S.A. (WSE:SLV) Will See A Huge Pay Rise This Year

Jun 14

Earnings Report: Selvita S.A. Missed Revenue Estimates By 7.1%

May 26

Recent updates

Is Selvita (WSE:SLV) Using Too Much Debt?

Sep 26

It's Unlikely That The CEO Of Selvita S.A. (WSE:SLV) Will See A Huge Pay Rise This Year

Jun 14

Earnings Report: Selvita S.A. Missed Revenue Estimates By 7.1%

May 26

Selvita's (WSE:SLV) Solid Earnings May Rest On Weak Foundations

Apr 03

Selvita S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Apr 01

Here's Why We Don't Think Selvita's (WSE:SLV) Statutory Earnings Reflect Its Underlying Earnings Potential

Jan 22

Is Now The Time To Put Selvita (WSE:SLV) On Your Watchlist?

Dec 25

Did You Miss Selvita's (WSE:SLV) Impressive 113% Share Price Gain?

Dec 02

Rendement voor aandeelhouders

	SLV	PL Life Sciences	PL Markt
7D	-2.7%	-5.3%	-1.2%
1Y	-9.7%	-12.3%	3.2%

Rendement versus industrie: SLV exceeded the Polish Life Sciences industry which returned -12.3% over the past year.

Rendement versus markt: SLV underperformed the Polish Market which returned 3.2% over the past year.

Prijsvolatiliteit

Is SLV's price volatile compared to industry and market?
SLV volatility
SLV Average Weekly Movement	5.5%
Life Sciences Industry Average Movement	6.6%
Market Average Movement	5.0%
10% most volatile stocks in PL Market	8.5%
10% least volatile stocks in PL Market	3.1%

Stabiele aandelenkoers: SLV has not had significant price volatility in the past 3 months compared to the Polish market.

Volatiliteit in de loop van de tijd: SLV's weekly volatility (5%) has been stable over the past year.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2007	387	Boguslaw Sieczkowski	selvita.com

Selvita S.A. is wereldwijd actief als organisatie voor contractonderzoek. Het bedrijf biedt diensten aan op het gebied van AI-driven drug discovery, antibody drug discovery, structurele biologie, recombinante eiwitproductie, assay-ontwikkeling en screening, computer-aided drug design, medicinale en synthetische chemie, scale-up, analytische en vaste stof chemie, ADME/DMPK, in vitro en in vivo farmacologie, translationeel onderzoek en toxicologie. Het ontwikkelt ook geneesmiddelen voor therapeutische gebieden, zoals oncologie, infectieziekten, auto-immuun/immunologie, neurologie, luchtwegen en andere.

Selvita S.A. Samenvatting

Hoe verhouden de winst en inkomsten van Selvita zich tot de beurswaarde?
SLV fundamentele statistieken
Marktkapitalisatie	zł985.69m
Inkomsten(TTM)	zł47.40m
Inkomsten(TTM)	zł329.02m

20.8x

Koers/Winstverhouding

3.0x

P/S-verhouding

Is SLV overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
SLV resultatenrekening (TTM)
Inkomsten	zł329.02m
Kosten van inkomsten	zł70.13m
Brutowinst	zł258.89m
Overige uitgaven	zł211.49m
Inkomsten	zł47.40m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

Nov 21, 2024

Winst per aandeel (EPS)	2.58
Brutomarge	78.69%
Nettowinstmarge	14.41%
Schuld/Eigen Vermogen Verhouding	39.8%

Hoe presteerde SLV op de lange termijn?

Bekijk historische prestaties en vergelijking

SLV Overzicht aandelen

Beloningen

Risicoanalyse

Selvita S.A. Concurrenten

WSE:SVE

zł304.3m

BIT:FF

€204.2m

SEHK:1521

HK$1.8b

NSEI:TARSONS

₹21.7b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Second quarter 2024 earnings released: zł0.55 loss per share (vs zł0.43 profit in 2Q 2023)

Is Selvita (WSE:SLV) Using Too Much Debt?

Now 21% overvalued

It's Unlikely That The CEO Of Selvita S.A. (WSE:SLV) Will See A Huge Pay Rise This Year

Earnings Report: Selvita S.A. Missed Revenue Estimates By 7.1%

First quarter 2024 earnings released: zł0.12 loss per share (vs zł0.14 profit in 1Q 2023)

Recent updates

Second quarter 2024 earnings released: zł0.55 loss per share (vs zł0.43 profit in 2Q 2023)

Is Selvita (WSE:SLV) Using Too Much Debt?

Now 21% overvalued

It's Unlikely That The CEO Of Selvita S.A. (WSE:SLV) Will See A Huge Pay Rise This Year

Earnings Report: Selvita S.A. Missed Revenue Estimates By 7.1%

First quarter 2024 earnings released: zł0.12 loss per share (vs zł0.14 profit in 1Q 2023)

Selvita S.A. (WSE:SLV) acquired PozLab sp. z o.o from YouNick Mint Sp. z o.o.

Selvita's (WSE:SLV) Solid Earnings May Rest On Weak Foundations

Selvita S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Selvita S.A. Launches Biologic Drug Discovery and Development Services

Price target decreased by 15% to zł70.18

Selvita S.A. to Report First Half, 2024 Results on Sep 25, 2024

Third quarter 2023 earnings released

Selvita S.A. (WSE:SLV) Analysts Just Cut Their EPS Forecasts Substantially

We Think Selvita (WSE:SLV) Can Stay On Top Of Its Debt

First quarter 2023 earnings released

Selvita S.A., Annual General Meeting, Jun 27, 2023

Here's Why Selvita (WSE:SLV) Has Caught The Eye Of Investors

Price target decreased by 11% to zł86.10

Selvita S.A. to Report Q3, 2023 Results on Nov 15, 2023

Now 21% undervalued

Selvita S.A. has completed a Follow-on Equity Offering in the amount of PLN 78.7 million.

Second quarter 2022 earnings released

Now 21% undervalued

Selvita (WSE:SLV) Seems To Use Debt Quite Sensibly

Now 22% undervalued

Selvita S.A., Annual General Meeting, Jun 30, 2022

First quarter 2022 earnings: Revenues exceed analyst expectations

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

These 4 Measures Indicate That Selvita (WSE:SLV) Is Using Debt Reasonably Well

Selvita Announces Management Changes

Third quarter 2021 earnings: Revenues exceed analyst expectations

Second quarter 2021 earnings released

First quarter 2021 earnings released

If You Like EPS Growth Then Check Out Selvita (WSE:SLV) Before It's Too Late

Investor sentiment improved over the past week

New 90-day high: zł63.20

Here's What Selvita S.A.'s (WSE:SLV) Shareholder Ownership Structure Looks Like

Here's Why We Don't Think Selvita's (WSE:SLV) Statutory Earnings Reflect Its Underlying Earnings Potential

New 90-day high: zł58.60

Selvita S.A. to Report Q1, 2021 Results on May 26, 2021

Investor sentiment improved over the past week

Selvita S.A. (WSE:SLV) completed the acquisition of Fidelta D.O.O. from Galapagos NV (ENXTAM:GLPG).

New 90-day high: zł49.30

Is Now The Time To Put Selvita (WSE:SLV) On Your Watchlist?

Did You Miss Selvita's (WSE:SLV) Impressive 113% Share Price Gain?

Third quarter 2020 earnings released: EPS zł0.24

Selvita S.A. (WSE:SLV) signed an agreement to acquire 100% stake in Fidelta D.O.O. from Galapagos NV (ENXTAM:GLPG) for an enterprise value of €31.2 million.

New 90-day low: zł39.70

New 90-day low: zł41.40

First half earnings released

Rendement voor aandeelhouders

Prijsvolatiliteit

Over het bedrijf

Selvita S.A. Samenvatting

20.8x